Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of non-glycosylated, recombinant human IL.sub.2 in reduced form

Administration of non-glycosylated, recombinant human IL.sub.2 in reduced form

US Patent 5874076 · Granted Feb 23, 1999

Estimated economic value: $792,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazole derivatives, preparation thereof, and therapeutic use thereof2013
Sucrose phosphate synthetase (SPS), a preparation method and cDNA therefor, and 2004
Sucrose phosphate synthase (SPS), its process for preparation its cDNA, and util2004
Modification of sucrose phosphate synthase in plants1999
Saccharose phosphate synthetase (SPS), a preparation method and CDNA therefor, a1999
Non-glycosylated, recombinant human IL .sub.2 in reduced form1998
Non-glycosylated, recombinant human IL .sub.2 in reduced form1998
Non-glycosylated, recombinant human IL .sub.2 in reduced form1998
Sucrose phosphate synthetase isolated from maize1998
Sucrose phosphate synthase (SPS), its process for preparation its cDNA, and util1997
Treatment method of ovarian cancer using interferon gamma1993
Preparation process for a protein containing at least one intramolecular disulph1993